1. Home
  2. PAHC vs TNDM Comparison

PAHC vs TNDM Comparison

Compare PAHC & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • TNDM
  • Stock Information
  • Founded
  • PAHC 1946
  • TNDM 2006
  • Country
  • PAHC United States
  • TNDM United States
  • Employees
  • PAHC N/A
  • TNDM N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • TNDM Medical/Dental Instruments
  • Sector
  • PAHC Health Care
  • TNDM Health Care
  • Exchange
  • PAHC Nasdaq
  • TNDM Nasdaq
  • Market Cap
  • PAHC 968.3M
  • TNDM 1.1B
  • IPO Year
  • PAHC 2014
  • TNDM 2013
  • Fundamental
  • Price
  • PAHC $31.10
  • TNDM $15.85
  • Analyst Decision
  • PAHC Hold
  • TNDM Buy
  • Analyst Count
  • PAHC 4
  • TNDM 13
  • Target Price
  • PAHC $24.50
  • TNDM $32.15
  • AVG Volume (30 Days)
  • PAHC 298.9K
  • TNDM 1.6M
  • Earning Date
  • PAHC 08-27-2025
  • TNDM 08-06-2025
  • Dividend Yield
  • PAHC 1.54%
  • TNDM N/A
  • EPS Growth
  • PAHC 140.17
  • TNDM N/A
  • EPS
  • PAHC 0.78
  • TNDM N/A
  • Revenue
  • PAHC $1,190,682,000.00
  • TNDM $982,951,000.00
  • Revenue This Year
  • PAHC $28.33
  • TNDM $8.91
  • Revenue Next Year
  • PAHC $13.78
  • TNDM $11.04
  • P/E Ratio
  • PAHC $39.84
  • TNDM N/A
  • Revenue Growth
  • PAHC 19.12
  • TNDM 27.65
  • 52 Week Low
  • PAHC $16.16
  • TNDM $15.17
  • 52 Week High
  • PAHC $31.48
  • TNDM $48.24
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 85.38
  • TNDM 26.23
  • Support Level
  • PAHC $24.59
  • TNDM $15.80
  • Resistance Level
  • PAHC $30.59
  • TNDM $17.12
  • Average True Range (ATR)
  • PAHC 0.86
  • TNDM 1.00
  • MACD
  • PAHC 0.53
  • TNDM -0.37
  • Stochastic Oscillator
  • PAHC 97.92
  • TNDM 11.31

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Share on Social Networks: